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Escherichia coli is the leading cause of urinary tract infection, one of the most common
bacterial infections in humans. Despite this, a genomic perspective is lacking regarding the
phylogenetic distribution of isolates associated with different clinical syndromes. Here, we
present a large-scale phylogenomic analysis of a spatiotemporally and clinically diverse set of
907 E. coli isolates, including 722 uropathogenic E. coli (UPEC) isolates. A genome-wide
association approach identifies the (P-fimbriae-encoding) papGII locus as the key feature
distinguishing invasive UPEC, defined as isolates associated with severe UTI, i.e., kidney
infection (pyelonephritis) or urinary-source bacteremia, from non-invasive UPEC, defined as
isolates associated with asymptomatic bacteriuria or bladder infection (cystitis). Within the E.
coli population, distinct invasive UPEC lineages emerged through repeated horizontal
acquisition of diverse papGII-containing pathogenicity islands. Our findings elucidate the
molecular determinants of severe UTI and have implications for the early detection of this
pathogen.
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In humans, Escherichia coli is both a commensal and apathogen capable of causing intestinal and extraintestinaldisease. In the urinary tract, E. coli causes a wide range of
clinical syndromes that includes, from less to more severe,
asymptomatic bacteriuria (ABU), bladder infection (cystitis),
kidney infection (pyelonephritis), and urinary-source bacteremia.
An estimated half of all E. coli bloodstream infections originate
from the urinary tract1–3.
E. coli strains with a special ability to cause urinary-tract
infection (UTI) are classified as uropathogenic E. coli (UPEC).
UPEC has further been grouped with E. coli strains that cause
(non-urinary-source) bacteremia, meningitis, and prostatitis as
extraintestinal pathogenic E. coli (ExPEC)4. UPEC are considered
to be opportunistic pathogens, with the human gut as their
reservoir5. The different pathotypes of intestinal pathogenic E.
coli (enteropathogenic E. coli [EPEC], enterohemorrhagic E. coli
[EHEC], enterotoxigenic E. coli [ETEC], enteroinvasive E. coli
[EIEC], and enteroaggregative E. coli [EAEC]) are differentiated
genotypically by their characteristic virulence genes. In contrast,
E. coli isolates are often classified presumptively as ExPEC and/or
UPEC according to their site of infection and isolation, irre-
spective of their intrinsic virulence, which usually is unknown6,7.
Although multiple urovirulence factors and their importance in
UTI pathogenesis have been described, genotypical features
that distinguish UPEC from non-pathogenic E. coli remain
incompletely defined5. The identification of defining UPEC fea-
tures is hampered by the large number of potentially redundant
bacterial virulence-associated genes (VAGs), a shared habitat
with commensal E. coli in the intestinal microbiota, and varying
host susceptibility to UTI8. UTI pathogenesis is hence assumed to
be determined by a complex interplay of bacterial and host
factors.
The E. coli population is subdivided into phylogenetic groups
(phylogroups) A, B1, B2, C, D, F, and G, and cryptic clades, with
ExPEC and UPEC strains deriving predominantly from phy-
logroups B2 and D. Strains from phylogroups B2 and D typically
have more VAGs than do those from phylogroups A and B1,
which are associated with commensal and intestinal pathogenic E.
coli4,9,10. Phylogroups B2 and D encompass the pandemic UPEC
lineages clonal complex (CC) 69, CC73, CC95, and CC131, which
are responsible for most cases of E. coli cystitis, pyelonephritis,
and bloodstream infection worldwide. This predominance in
extraintestinal E. coli infections of just a few E. coli lineages,
among the hundreds that exist, suggests that specific genetic
determinants facilitate the expansion, global spread, and virulence
of these pathogens11. Increased antimicrobial resistance (AMR)
might have contributed to the recent dissemination of CC69 and
CC131, whereas it cannot explain the epidemiologic success of
the largely susceptible lineages CC73 and CC9512–14.
Previous phylogenomic analyses provided important insights
into the population structure, virulence associations, and AMR of
ExPEC and UPEC12,13,15–18. However, a specific genomic analysis
of invasive UPEC strains—defined here as those associated with
severe UTI (pyelonephritis or urinary-source bacteremia)—is
lacking. PCR-based studies targeting subsets of VAGs have
identified a greater frequency of various VAGs in pyelonephritis
and urinary-source bacteremia isolates, as compared to ABU,
cystitis, or fecal isolates19–22. These VAGs include papGII, which
encodes one of several PapG tip adhesin variants of P fimbriae.
PapGII binds to the globoseries of glycosphingolipids on uroe-
pithelial cells and transcriptionally regulates host gene expression
in kidney cells, leading to a pyelonephritis-associated IRF-7
response23. Like many other E. coli VAGs, the pap operon
encoding P fimbriae lies on pathogenicity islands (PAIs)24. PAIs
are large horizontally transferable genetic elements assumed to
play an important role in the evolution of pathogenic E. coli25.
In this study, we used a genomics approach to investigate the
population structure, virulence determinants, and evolution of
invasive UPEC isolates, as compared to non-invasive UPEC iso-
lates, which were defined here as those associated with asymp-
tomatic bacteriuria (ABU) or cystitis. Fecal isolates not associated
with disease were included to investigate their genetic similarity
with UPEC. Our analysis identified a small number of enduring
and broadly distributed invasive UPEC lineages that seemingly
emerged after independent horizontal acquisitions of papGII.
Results
Invasive UPEC cluster in distinct phylogenetic lineages. We
analyzed whole-genome sequences of 722 total UPEC isolates—
including 385 invasive UPEC isolates (from five collections) and
337 non-invasive UPEC isolates (from nine collections)—and 185
fecal isolates (from two collections). The 722 UPEC isolates were
so defined based on their source of isolation and associated
clinical presentation, whereas the fecal isolates were not asso-
ciated with UTI or intestinal infection (Supplementary Note 1
gives the various source collections’ inclusion criteria). The 16
isolate collections had a broad spatiotemporal distribution: they
derived from various locales in Europe and the United States and
spanned nearly four decades (1981–2018) (Supplementary Fig. 1,
Table 1). For four of these collections (LtABU, MC_pye,
MVAST_ABU, UZA_uro), the isolates (n= 151) were sequenced
within this study; for the remaining 12 collections (n= 756 iso-
lates) the sequence data were publicly available (Supplementary
Table 1).
Phylogenetic analysis revealed a non-random phylogenetic
distribution of the three clinical phenotypes, i.e., invasive UPEC,
non-invasive UPEC, and fecal isolates. Invasive and non-invasive
UPEC isolates alike were predominantly (86% and 71%,
respectively) from phylogroups B2 and D; by contrast, fecal
isolates were more evenly distributed among phylogroups A, B1,
B2, and D (Supplementary Table 2, Supplementary Note 2).
Among the invasive UPEC isolates the 11 dominant CCs were
CC12, CC14, CC23, CC31, CC62, CC69, CC73, CC95, CC131,
CC144, and CC405 (the corresponding sequence types (STs) are
shown in Fig. 1). These 11 dominant CCs accounted collectively
for 82% of all invasive UPEC isolates, with limited variation
between collections (Supplementary Fig. 2). Moreover, within
these CCs, invasive and non-invasive UPEC isolates tended to
cluster into distinct sublineages (Fig. 1). Most of these CCs
encompassed one or multiple sublineages that were significantly
enriched with invasive UPEC isolates (P < 0.05, for proportion of
invasive UPEC isolates within vs. outside the sublineage;
Supplementary Data 2), giving 12 sublineages associated with
invasiveness. Within these 12 sublineages combined, 86% of all
UPEC isolates were invasiveness-associated, vs. 39% of other
UPEC isolates.
Invasive UPEC lineages emerge after acquisition of papGII+
PAIs. A pan-genome-wide association study (pan-GWAS) com-
paring invasive vs. non-invasive UPEC isolates that included
30,705 clusters of orthologous genes (COGs) identified significant
associations with invasiveness for two genomic loci, papGII and
iuc, which encodes aerobactin biosynthesis (Fig. 2, Table 2). An
alternative, gene-prediction-independent GWAS approach based
on De Bruijn graphs and linear mixed models (DBGWAS26)
confirmed papGII as the most significantly invasiveness-
associated genomic region (Supplementary Table 3, Supplemen-
tary Data 3). Overall, papGII was present in 63.9% of invasive
UPEC isolates, as compared with 15.4% of non-invasive UPEC
isolates (OR= 9.7, P= 6.0 × 10−42) and, for reference, 19% of
fecal isolates (OR= 7.6, P= 9.1 × 10−25).
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This significant association of papGII with invasive UPEC was
found irrespective of host gender or age (Supplementary Table 4).
In addition, within each clinical phenotype (invasive UPEC, non-
invasive UPEC, and fecal) the frequency of papGII varied only
modestly between collections, ranging by collection from 58 to
77% for invasive UPEC, vs. from 0 to 29% for non-invasive
UPEC, and 19 to 20% for fecal isolates; the observed modest
variation likely reflected the collections’ differing settings and
patient inclusion criteria (Supplementary Fig. 3). The presence of
papGII (n= 333 isolates) coincided closely with the above-
defined invasive UPEC-enriched sublineages (Fig. 1); 88% of
isolates in these sublineages carried papGII, vs. 19% of other
isolates (P < 0.001).
The 333 papGII-positive (papGII+) isolates clustered robustly
in 14 discrete lineages, which thus were termed papGII+ lineages
(Fig. 3a). CC12, CC14, CC31, CC59, CC62, CC69, CC95, CC131,
CC144, and CC405 encompassed one such papGII+ sublineage
each. CC73 showed a heterogenous population structure that
encompassed four distinct papGII+ lineages (called L1–L4), as
identified by using a second hierarchic level of clustering. Most
papGII+ lineages comprised isolates from different regions that
had been collected during different time intervals over 40 years,
suggesting enduring, broadly distributed lineages rather than
transient and/or geographically restricted subpopulations (Sup-
plementary Fig. 2).
The genetic context of papGII in the 14 papGII+ lineages was
usually unclear from short-read sequencing data only, but could
be resolved for 35 isolates, including at least one from each
papGII+ lineage. These 35 genomes comprised 14 publicly
available, high-quality assemblies and 21 complete or near-
complete assemblies obtained in-house using long-read sequen-
cing (Supplementary Data 5). Six of the 35 genomes harbored
more than one papGII locus. The total of 42 papGII genes were
each part of a complete pap operon (papGII operons) that
consisted of 11 genes (papIBAHCDJKEFG), with sequence
variation found for papA (major fimbrial subunit) and papE
(minor fimbrial subunit) (Supplementary Fig. 4) as described
previously27,28. The papGII genes always occurred on PAIs, i.e.,
genomic regions flanked by an integrase, integrated into the
chromosome at one of six specific loci, and absent in
phylogenetically related isolates.
These 42 resolved papGII-containing (i.e., papGII+) PAIs were
integrated directly downstream of the tRNA genes pheV, pheU,
selC, or leuX, or into the gln or ula operons (Supplementary
Fig. 5). In addition, the papGII+ PAI insertion site could be
determined in 170 other papGII+ isolates (171 putative PAIs) for
which only short-read assemblies were available. Overall, the
tRNA-pheV and tRNA-pheU sites accounted for 194 (91%) of all
213 identified papGII+ PAI insertion sites; the remaining 9%
were divided between four other tRNA sites, which accounted for
0.5–4% of the PAIs each (Supplementary Data 7). PAIs inserted
at the (predominant) tRNA-pheV and tRNA-pheU sites shared
the same integrase gene, whereas those inserted at the other four
sites had distinct insertion-site-specific integrase sequences
(Supplementary Fig. 6). Complete or near-complete assemblies
of three papGII+ isolates each from CC144 and CC12 revealed
the sporadic presence of two or three papGII operons, each on a
distinct PAI (Supplementary Fig. 7).
The 42 resolved papGII+ PAIs showed a highly diverse gene
content: the only consistently present element was the papGII
operon (Fig. 3b, Supplementary Fig. 8a). This is in line with the
concept that PAIs are organized in mosaic-like structures,
consisting of a flexible pool of gene modules29,30. The papGII+
PAIs ranged in size from 28 kb (26 genes) to 146 kb (140 genes).
They contained from 12 to 31 VAGs each (including the 11 pap
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(Supplementary Fig. 8a, Supplementary Table 5). They also
contained multiple hypothetical genes, phage gene remnants, and
IS elements, but no AMR genes. Based on sequence similarity, the
42 resolved papGII+ PAIs could be grouped into six types, I
through VI (Supplementary Fig. 8b). The incompletely resolved
papGII+ PAIs of 199 additional isolates could be assigned to
these six types by mapping reads to the resolved PAIs
(Supplementary Data 11). Within a given papGII+ lineage, most
papGII+ PAIs were fully conserved or differed only by a few IS
elements, suggesting a single PAI acquisition event per papGII+
lineage (Fig. 3a). By contrast, the sporadic occurrence of similar
PAIs in distantly related isolates suggested horizontal gene
transfer events (Supplementary Fig. 9).
Exceptionally, one invasive UPEC-enriched sublineage was not
characterized by the presence of papGII: although phylogroup C
(represented almost entirely by CC23 isolates: 24/25, 96%)
comprised mainly invasive UPEC isolates (17/25, 68%), only
three CC23 isolates contained papGII. Screening of CC23 isolates
for known E. coli VAGs identified the afaVIII operon
(afaABCDE-VIII) in eight (of 14) papGII-negative invasive UPEC
isolates (Fig. 1). afa genes encode afimbrial structures that
mediate adhesion and invasion31; some of these, including
AfaEVIII, have been associated with pyelonephritis32,33. Over
the entire dataset, afaVIII occurred in 15 invasive UPEC isolates
(3.9%), as compared with only two non-invasive UPEC isolates
(0.6%; OR= 6.8, P= 0.003) and one fecal isolate (0.5%: OR= 7.4,
P= 0.03). These afaVIII operons were usually complete and the
afa genes were conserved, apart from minor sequence variation
within afaEVIII (Supplementary Fig. 10). Long-read sequencing
of CC23 isolate US26 resolved afaVIII on an 82-kb genomic
island that was integrated at the tRNA-argW site. This hybrid
pathogenicity-resistance island carried one additional VAG,
agn43, which encodes antigen 43 (Ag43), a protein involved in
biofilm formation, adhesion, and autoaggregation34, plus 10 genes
predicted to confer resistance to beta-lactams, sulfonamides,
phenicols, aminoglycosides, or mercury (Supplementary Fig. 11).
UPEC isolates harbor a diverse VAG repertoire. The UPEC
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Fig. 1 Phylogeny of 907 Escherichia coli isolates associated with different clinical phenotypes. Midpoint-rooted maximum-likelihood phylogenetic tree
based on 109,023 variable sites identified in a core genome alignment (1.136Mbp). Ring 1, 2, and 3 denote predominant sequence types (ST),
corresponding clonal complexes (CC), and phylogroup assignment. Clinical phenotypes are labeled according to the key (ring 4). Phylogenetic clusters
identified using BAPS (Bayesian analysis of population structure) significantly enriched with invasive UPEC isolates are highlighted in ring 5. The presence
of the afaVIII and papGII (blue and red dots) across the phylogeny is annotated in ring 6. The scale bar indicates the number of substitutions per site in the
core genome alignment. A tree with bootstrap support values is provided in Supplementary Fig. 20. The tree was visualized using iTOL89. An interactive
visualization of this phylogenetic tree can be found out at https://microreact.org/project/O4QAYAJWw.
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which were located on papGII+ PAIs (Fig. 4a, Supplementary
Fig. 8a). VAGs identified on one or more of the 42 resolved
papGII+ PAIs included iron uptake systems (iuc, ireA, iha, fbp,
fec), fimbrial genes (fim, ucl), invasins (tia, hek, hra2), toxins
(cnf1, hly), autotransporters (sat, agn43), toxin-antitoxin modules
(cdiA/cdiB), and sisA and sisB, which in mice downregulate the
kidney’s immune response during E. coli infection35.
The number of VAGs correlated with the isolates’ associated
disease severity. Genomes from invasive UPEC isolates contained
significantly more VAGs than did those from cystitis isolates, and
genomes from cystitis isolates contained significantly more VAGs
than did those from ABU isolates (Fig. 4a). To account for this
observation, cystitis isolates were analyzed separately from ABU
isolates. To examine functional correlations, VAGs were grouped
by presumptive functional class (Supplementary Data 8). With
VAGs stratified by functional class, as compared with either the
cystitis or ABU isolates the invasive UPEC isolates had a higher
prevalence of VAGs related to iron uptake and immune evasion/
modulation. In addition, as compared with ABU isolates, they
had a higher prevalence of VAGs related to secretion systems/
autotransporters, adhesion/invasion (attributable to pap genes
only), toxins, and bacteriocins (Supplementary Table 6a).
The number of VAGs varied significantly by phylogroup,
analogous to the observed phylogroup-specific segregation of
clinical phenotypes. Specifically, the number of VAGs was
significantly higher in UPEC-associated phylogroups (B2, C, D,
F) than in those associated with fecal isolates (A and B1)
(Supplementary Fig. 12, Supplementary Table 7). Within
phylogroup B2, the total number of VAGs did not differ
significantly between invasive UPEC isolates and cystitis isolates,
but was significantly higher among invasive UPEC isolates as
compared to ABU isolates, a difference that is possibly attributable
to the acquisition or loss of single PAIs (Supplementary Fig. 13,
Supplementary Table 6b). By contrast, among papGII+ isolates
the number of VAGs did not differ significantly by clinical source,
i.e., between invasive UPEC, cystitis, ABU, or fecal isolates
(Supplementary Table 8).
Iron acquisition systems are regarded as critical virulence factors
of UPEC36. Of the 22 presumably partially redundant iron uptake
systems described for E. coli37–39, the average number of such
systems per isolate was significantly higher among invasive UPEC
isolates (15.6) than among cystitis isolates (14.3), ABU isolates
(14.0), or fecal isolates (12.9) (Supplementary Table 9). papGII+
isolates carried, on average, 16.3 iron uptake systems (vs. 13.5
among papGII-negative isolates, P < 0.001). As noted generally for
VAGs, the average number of iron uptake systems per isolate
correlated with phylogenetic background, with the highest values
for (invasiveness-associated) phylogroups B2 and F (Fig. 4b,
Supplementary Table 9). Apart from iron acquisition systems,
previous studies found associations with uropathogenicity for
multiple other VAGs40–43. In agreement with these findings, many
of these uropathogenicity-associated VAGs were here found in
both invasive and non-invasive UPEC; and were associated with
specific CCs rather than invasiveness (Supplementary Fig. 14).
Apart from papGII, only the iuc (i.e., aerobactin) locus, which
in E. coli consists of six genes (shiF, iucA, iucB, iucC, iucD, iutA),
reached pan-genome-wide statistical significance for invasive vs.
non-invasive UPEC isolates (P= 7.6 × 10−21). The iuc locus
occurred in 73% of invasive UPEC isolates, vs. 36% of cystitis
isolates (P < 0.001, OR= 4.7) and 48% of ABU isolates (P < 0.001,
OR= 2.9). It also was associated specifically with papGII,
occurring in 86% of papGII+ isolates vs. 33% of papGII-negative
isolates (P < 0.001, OR= 13.0). A complete iuc locus (100%
sequence coverage) was identified in 92% of the 482 iuc+ isolates.
In the remaining 38 iuc+ isolates the iuc locus either could not be
resolved (15 isolates) or showed disruptions (23 isolates). We
identified three distinct, highly conserved iuc locus architectures.
These included (i) shiF/iuc/iutA1, which was usually associated
with type II papGII+ PAIs; (ii) shiFp/iuc/iutA2, which was part of
large IncFII plasmids and corresponds to the iuc5 locus described
in Klebsiella isolates44; and (iii) shiF/iuc/iutA2, which was part of
the widely distributed PAIABU83972-pheV-like islands or, less
commonly, of PAIIAI39-pheV-like islands (Supplementary Fig. 15).
The distribution of the non-aerobactin iron uptake systems by
clinical phenotype and phylogroup is described in Supplementary
Note 3 and Supplementary Table 10.
papGII+ sublineages within CC69, CC95, and CC73. The three
pandemic UPEC lineages CC69, CC95, and CC73 comprised,
collectively, 42% (301/722) of the UPEC isolates and 68% (229/
333) of the papGII+ isolates, as compared with 23% of the fecal
isolates. Each of these lineages exhibited gain, loss, and/or rear-
rangements of papGII+ PAIs, which segregated by lineage.
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Fig. 2 Manhattan plot for pan-genome-wide associations for invasive vs. non-invasive UPEC. Data are based on 30,705 clusters of orthologous genes
(COGs) identified in 722 UPEC isolates. Fecal isolates were not considered in this analysis because they present no urinary phenotype. The plot shows
genes assigned to 4764 unique COGs identified in the genome of reference strain UMN026 (CC69). Each dot represents one COG. The vertical axis
denotes raw P values of Fisher’s exact statistics. To account for the effects of sample size and population structure, the genome-wide significance threshold
(dotted line, P= 1.42 × 10−18) was inferred from a simulated dataset using treeWAS. The horizontal axis gives the nucleotide position in the chromosome.
COGs part of pathogenicity islands (PAIs), prophage regions, or the two plasmids of UMN026 are color-labeled, including the High Pathogenicity Island
(HPI) and PAIUMN026-pheV, a papGII-containing PAI. The remaining 25,941 COGs of the pan-genome that did not map to UMN026 were not pan-genome-
wide significant (Supplementary Fig. 21).
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Within CC69, 53 of 54 papGII+ isolates formed a mono-
phyletic clade and shared a conserved PAI. This suggests that this
clade emerged after a single acquisition event involving a type II
papGII+ PAI in a common cladal ancestor (Fig. 5).
Similarly, within CC95, isolates of the papGII+ sublineage
shared a conserved type V PAI. Occurrence of the papGII+ PAI
at either the tRNA-pheU or tRNA-pheV site within one branch
suggests possible excision and re-integration events within CC95
isolates (Supplementary Fig. 16). The population structure,
supported by high-confidence bootstrap values, suggests that
the PAI was present in the most recent common ancestor of all
CC95 isolates but subsequently was lost in one branch (Fig. 5).
Interestingly, this papGII-negative branch, which corresponds
with so-called CC95 subgroup B45, consisted mainly of non-
invasive UPEC isolates and contained a sublineage characterized
by integration of a papGIII-containing PAI at the tRNA-leuX site.
Within CC73, all four papGII+ sublineages (here termed
CC73-L1, -L2, -L3, and -L4) were part of a single large
monophyletic branch characterized by the presence of iuc (Fig. 5).
The occurrence of different papGII+ PAI types within this iuc-
containing branch suggests different papGII+ PAI acquisition
events within each sublineage. Alternatively, the different
sublineages might have evolved from a common ancestor that
contained multiple papGII+ PAIs, such as seen in reference
pyelonephritis isolate CFT073, which is phylogenetically similar
to isolates of this branch and harbors distinct papGII+ PAIs at its
two tRNA-phe sites.
The four papGII+ CC73 sublineages differed for the composi-
tion and insertion site(s) of their PAIs. Specifically, several isolates
within sublineages CC73-L1 and CC73-L2, carried a type V PAI at
the tRNA-pheU site, whereas others carried type III PAIs, including
PAI194-Pyelo-pheU and PAIUS32-pheU, which seemingly resulted
from recombination between a type V PAI and a papGIII-
containing PAI (Supplementary Fig. 17). By contrast, isolates
within sublineage CC73-L3 carried a type II PAI at the tRNA-pheV
site, and those within sublineage CC73-L4 carried a type IV PAI.
This PAI was integrated adjacent to a PAIABU83972-pheV-like island
at the tRNA-pheV site.
Notably, isolates from the large iuc-containing branch within
CC73 carried one of two iuc locus configurations, i.e., either (1)
shiF/iuc/iutA1, on type II papGII+ PAIs (found in CC73-L3), or
(2) shiF/iuc/iutA2, on PAIABU83972-pheV-like islands (found in
CC73-L1, CC73-L2, and CC73-L4). The latter was also found in
isolates from sublineages associated with papGII-negative, non-
invasive UPEC isolates, such as prototypic ABU strain ABU83972
and probiotic strain Nissle1917. These two iuc-containing PAIs
might have been acquired independently or could have evolved
from the same PAI, after its acquisition by a common CC73
ancestor.
papGII+ sublineages within the pandemic UPEC lineage
CC131. The recently emerged lineage CC131 (dominated by
ST131) is currently the leading cause of multi-drug-resistant E. coli
UTI and bloodstream infections12,46. Although our main dataset
comprises isolates collected over almost 40 years, it includes few
CC131 isolates (n= 59), precluding a robust analysis of this line-
age. Accordingly, to investigate the distribution of papGII within
CC131 we combined these 59 CC131 isolates with 1017 additional
publicly available CC131 isolates, which had, however, limited
associated metadata (Supplementary Table 11, Supplementary
Data 10). This analysis identified in all three main CC131 clades
(A, B, and C) sublineages enriched with papGII+ isolates (Sup-
plementary Fig. 18). The largest papGII+ fractions occurred within
both subclade C2 (i.e., H30Rx; 216/521 isolates, 41%) and the
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Fig. 3 Genetic characterization of papGII+ E. coli lineages and papGII+PAIs. a Maximum-likelihood phylogenetic tree of 333 papGII+ isolates based on
192,889 variable sites identified in a core genome alignment (2.573Mbp). Phylogenetic lineages, defined by patristic distances, are collapsed on single nodes
(indicated with triangles). Fourteen papGII+ lineages with >5 isolates (red triangles) were identified and named after their clonal complex (+L). Isolates in CC73
were investigated on an additional level of hierarchy and assigned to four papGII+ lineages (CC73-L1 to -L4) to account for the subclonal population structure
with distinct characteristics. Each papGII+ lineage is labeled with the proportion of papGII+ pathogenicity island (PAI) types and insertion sites when their
identification was possible. The presence of papGII+ PAI types was identified in complete or near-complete assemblies or predicted using a read-mapping-
based approach. Fragmented assemblies, lack of resolved reference PAIs, or sequence deletions/insertions sometimes prevented the determination of the
specific papGII+ PAI family type and insertion site (shown in gray). The proportion of isolates carrying PAI- or plasmid-associated iuc loci, the frequency of
clinical phenotypes, and the total number of isolates are shown. The branch length of the outgroup (papGII-negative isolate 495_PUTI_Fec, clade I) was reduced
(dashed line). The scale bar indicates the number of substitutions per site in the core genome alignment. A tree with expanded nodes and bootstrap values is
shown in Supplementary Fig. 16. b Genetic organization of representative PAIs of the six identified papGII+ PAI types. The papGII operon, integrase gene, and
virulence-associated genes are highlighted. The gradient scale shows the level of nucleotide identity. PAI sequences were compared and visualized using
EasyFig110. The genetic organization of all 42 resolved papGII+ PAIs is shown in Supplementary Fig. 22.
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Despite its recent emergence, CC131 appeared to have
undergone multiple acquisitions of papGII+ PAIs. Among the
21 papGII+ CC131 isolates with complete or near-complete
assemblies, 20 contained a type III and one a type IV papGII+
PAI (Supplementary Table 12, Supplementary Fig. 19). Among
the remaining papGII+ CC131 isolates with available read data, a
read-mapping-based analysis identified type III papGII+ PAIs in
multiple isolates of clades A, B, and C, and, sporadically, type II,
type IV, type V, and type VI papGII+ PAIs in isolates of clades B
and C (Supplementary Fig. 18, Supplementary Data 12). Among
the 192 CC131 UPEC isolates with available clinical phenotype
data, papGII was significantly more prevalent among invasive
UPEC isolates (67/133, 50%) as compared to non-invasive UPEC
isolates (7/59, 12%: OR= 7.5, P < 0.001).
Discussion
In this study, we analyzed 907 E. coli isolates from individuals
with ABU, cystitis, pyelonephritis, or urinary-source bacteremia,
as well as from feces, thereby deriving a high-resolution popu-
lation structure of UPEC associated with these different clinical
contexts. The observed phylogenetic clustering of invasive UPEC
isolates underlines the importance of the corresponding lineage-
associated genetic determinants in UTI pathogenesis. Our large
collection size provided sufficient statistical power to establish a
genome-wide association of papGII with invasive disease, sug-
gesting a causal relationship. Associations of most other genes
were rejected by stringent statistical corrections for multiple
testing and population structure.
The gene papGII has been associated epidemiologically with
pyelonephritis and urinary-source bacteremia in directed, usually
PCR-based studies19–22,47, and was shown experimentally, with
varying degrees of rigor, to contribute to kidney infection in
murine and monkey models48–50. A key role for papGII in the
pathogenesis of human pyelonephritis was confirmed recently by
the finding that knock-in of papGII was sufficient to enable
the iuc-positive but normally non-pathogenic E. coli strain
ABU83972 (CC73, phylogroup B2) to cause pyelonephritis in
humans23. In that study, PapGII was shown to enter kidney cells
and to trigger renal tissue inflammation by reprogramming host
gene expression23. These findings, together with ours, support a
site (i.e., kidney)-specific and, hence, pathotype-defining role for
papGII. However, our data also identify a comparatively rare
locus, specifically afaVIII, as potential marker of invasive UPEC.
Apart from papGII, only the iuc locus exhibited a significant
pan-genome-wide association with invasive vs. non-invasive
UPEC. This suggests that iron scavenging, as mediated specifi-
cally by the aerobactin system (among multiple E. coli side-
rophores), is particularly important for tissue and bloodstream
invasion during UTI. Abundant evidence supports both a critical
role of iron uptake for UPEC and partial functional redundancy
among the multiple E. coli iron acquisition systems36. Here, iron
uptake was the virulence factor class most significantly enriched
in invasive UPEC isolates, as compared to non-invasive UPEC or
fecal isolates.
Previous studies identified fyuA (yersiniabactin siderophore)
and chuA (heme-binding protein) as important pathogenicity














































































Fig. 4 Number of virulence-associated genes (VAGs) and distribution of iron uptake systems. a Boxplots showing the number of VAGs per isolate by
clinical phenotype (fecal isolates, non-invasive UPEC isolates (asymptomatic bacteriuria (ABU), cystitis), and invasive UPEC isolates). papGII+ isolates are
indicated as red dots. Asterisks indicate significant differences (***P < 0.001, two-sided Mann–Whitney U test, Bonferroni-corrected). Exact P values are
reported in Supplementary Fig. 13. Boxplot center lines: median; box limits: upper and lower quartiles; whiskers extend from the hinges to the highest and
lowest values that are within 1.5×IQR of the hinges. Source data are provided in Supplementary Data 8. b Number of iron uptake systems (ring 2) per
isolate and presence of iuc (ring 3) visualized on the phylogenetic tree. Twenty-two different systems involved in iron uptake were identified in our dataset,
with 8–19 systems found per isolate. Phylogroups (ring 1) and isolates part of papGII+ lineages (ring 4) are labeled. The tree was visualized using iTOL89.
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adjustment for multiple comparisons and population structure,
fyuA and chuA did not discriminate between invasive and non-
invasive UPEC isolates, this does not exclude a role in general
uropathogenicity for them. For example, we showed a clear
association of fyuA and chuA with phylogroups B2, C, D, and F,
which together harbored 94% of invasive UPEC isolates and 75%
of non-invasive UPEC isolates. By contrast, chuA was absent and
fyuA was uncommon (prevalence 20–35%) in commensal-
associated phylogroups A and B1, suggesting that fyuA and
chuA might play a role in urinary-tract colonization for both
invasive and non-invasive UPEC. Future studies with specific
datasets from fecal and urinary E. coli isolates could resolve the
bacterial determinants of commensal vs. invasive and non-
invasive UPEC.
Although we focused on the role of bacterial determinants in
UTI pathogenesis, predisposing host factors also are critically
important. Here, some of the putative invasive UPEC isolates that
lacked recognized VAGs (including papGII) may have been
misclassified based solely on clinical criteria, and actually caused
their invasive infection due to host defense defects rather than
heightened pathogenic potential. Debilitated hosts are often
infected by E. coli strains with low intrinsic virulence, such as
those from phylogroup A or B1 and that produce fewer virulence
factors51, and papG is less common among invasive isolates from
compromised as compared with non-compromised patients52.
Conversely, a substantial fraction of the present cystitis and
ABU isolates, including strains that asymptomatically colonized
the urinary tract over months53, carried papGII, without causing
invasive infection. Apart from possible stochastic effects, this may
reflect in part the known variation in host susceptibility to UTI in
relation to specific host genetic polymorphisms54; conceivably,
these isolates’ corresponding source hosts may have been more
resistant to developing invasive UTI. In addition, the study’s
clinical phenotype assignments may have misrepresented some
strains’ virulence potential. For example, patients classified as
having cystitis may have received prompt antibiotic treatment
that prevented progression of papGII+ isolates to the kidneys, or
their urine samples might have been collected before symptoms
of pyelonephritis developed.
The observed preferential occurrence of papGII+ PAIs in
expanded lineages associated with invasive UPEC is similar to
observations of acquisitions of PAIs or plasmids linked to the
clonal expansion of atypical EPEC9 and ETEC lineages10.
Whereas most ETEC and atypical EPEC lineages in those studies
were from phylogroups A and B1, here all papGII+ lineages
belonged to phylogroups B2, D, and F. Consistent with previous
findings4, our data demonstrate that isolates of phylogroups B2,
C, D, and F carry greater numbers of VAGs than do isolates of
other phylogroups, even in the absence of papGII+ PAIs, sug-
gesting that such VAGs provide the genetic basis required to
colonize extraintestinal sites such as the human urinary tract.
This ability to colonize extraintestinal sites might be a pre-
condition for the stable maintenance of acquired papGII+ PAIs
and clonal expansion.
The spread of AMR among pathogenic E. coli poses a sig-
nificant threat to public health. In particular, the emergence of
papGII+ lineages within ST131 clades C1 and C2, which were
shown to have high levels of AMR against commonly used anti-
microbials to treat invasive UTI (ciprofloxacin, 3rd-generation
cephalosporines, trimethoprim-sulfamethoxazole)55,56, is con-
cerning. In addition to bacterial virulence and host factors, AMR
and associated treatment failure may impact the outcome of UTI,
if not the patient’s initial presentation. Here, invasiveness-
associated sublineages were found among both multi-drug resis-
tant clones (CC69 and CC131) and clones that typically exhibit
broad antibiotic susceptibility (CC73, CC95)12,13. Regardless of
their usual AMR status, all such invasiveness sublineages shared
the presence of papGII or afaVIII.
Considering the widespread presence of papGII+ PAIs and their
stable maintenance in successful E. coli lineages, we speculate that
PapGII confers a niche-specific selective advantage. P fimbriae with
PapGII might contribute to urinary-tract colonization and thereby
to pathogen transmission through shedding. Alternatively, PapGII
might contribute to gut colonization; indeed, phylogroup B2 iso-
lates that produce P fimbriae have been associated with increased
persistence in the human intestine57,58. PapGII might also play a
role in the colonization of zoonotic niches. Interestingly, papGII
was found in up to 60% of avian pathogenic E. coli isolates from
live or diseased poultry59–61. Human intestinal acquisition of
UPEC/ExPEC has been associated with animal contact, con-
sumption of high-risk food (including seafood, raw meat, or
vegetables), and direct transmission between humans13,62.
Previous studies demonstrated that UTI occurrence is linked to
the relative abundance of the causal clone in the host’s gut
microbiota, and modulation of the gut microbiota has been
suggested as a potential strategy to prevent UTI63,64. Here, papGII
+ isolates from feces genetically resembled clinical papGII+
isolates, supporting the concept that the human gut is a reservoir
of papGII+ isolates and that carriers might be predisposed to
invasive UTI. In our dataset, papGII+ isolates (i.e., putative
uropathogens) constituted ~20% of all fecal E. coli isolates.
Our study has notable limitations and strengths. Limitations
include (i) an intrinsic sampling bias due to the variation in the
distribution of E. coli clones, both over time and among different
human populations; (ii) a potential underestimation of the con-
tribution of rare variants or the combined effects of variants due
to our stringent statistical adjustment by GWAS, leading to fail-
ure to detect true associations; (iii) inaccessibility of data on
predisposing host factors, and (iv) reliance on observation/cor-
relation, not experimentation. In addition, gene presence does not
necessarily imply functional expression, and in vivo gene
expression levels are unknown for the present study isolates.
Notably, regulation of pap expression is complex65,66. Strengths
include (i) the large number of study isolates with well-
documented clinical phenotypes, (ii) the unbiased approach to
identify genome-wide associations of genes and lineages with
specific clinical syndromes, and (iii) use of a robust phylogeny in
combination with long-read sequencing data to elucidate key
evolutionary events.
In summary, our findings demonstrate that different UPEC
lineages tend to behave as either invasive or non-invasive patho-
gens. Whereas a combination of multiple VAGs is likely required
to colonize the urinary tract, papGII is specifically associated
with invasiveness. A few papGII+ lineages account for most
invasive UTIs across decades and continents, with recent or
ongoing papGII+ PAI acquisition events likely leading to the
emergence of new papGII+ lineages. These findings have impli-
cations for our understanding of the pathogenesis of invasive
UPEC and, hence, for potential surveillance and control measures.
Methods
Bacterial isolates and genomes of the main dataset. Genomes of 907 E. coli
isolates from multiple collections were analyzed. These included 185 fecal isolates
from human samples and 722 urinary-tract source extraintestinal isolates from
human subjects with ABU (n= 113), cystitis (n= 224), pyelonephritis (n= 73), or
urinary-source bacteremia (n= 312). Of these genomes, 738 originated from 13
publicly available collections (Supplementary Table 1). These were supplemented
with genomes of 18 reference strains and 151 isolates that were sequenced as part
of this study, including isolates from the collections LtABU, UZA_uro, MVAS-
T_ABU, and MC_pye. Strain details are listed in Supplementary Data 1.
LtABU collection. The LtABU collection comprises isolates associated with
long-term ABU obtained between 2017 and 2018 from non-catheterized residents
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(>65 years of age) of two long-term care facilities (OCMW Destelbergen and WZC
Immaculata Edegem) in Belgium. A total of 237 participants were screened for
bacteriuria (>105 CFU/ml) at up to four consecutive sampling timepoints over
three months: at baseline and after ~2, 10, and 12 weeks. Bacterial species were
identified using MALDI-TOF. The clonal relationship of consecutive E. coli
bacteriuria isolates from the same patients was analyzed using random amplifi-
cation of polymorphic DNA (RAPD) profiling. The RAPD assay consisted
of two PCR reactions containing primer 1247 (5′-AAGAGCCCGT-3′) or 1283
(5′-GCGATCCCCA-3′), respectively, as described by Nielsen et al.67. Amplification
was performed in 27 µL reactions with 1.5 µM primer, 0.2 mM dNTPs, 1.5 U
SuperTaq polymerase (SphaeroQ), the supplied polymerase buffer, and 2 µl 100-
fold diluted overnight culture. Cycling conditions were 15 min at 95 °C, 35 cycles of
1 min at 94 °C, 1 min at 38 °C (reaction primer 1247) or 36 °C (reaction primer
1283), and 2 min at 72 °C, followed by a final extension for 10 min at 72 °C.
Amplification products were separated on 1.5% agarose gels in TBE buffer (1 h,
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ChemiDoc). Long-term ABU was defined here as at least three consecutive positive
urine cultures covering a period of at least 10 weeks from participants without signs
or symptoms of a urinary-tract infection and resulting in the isolation of clones
with identical RAPD fingerprints. Forty-three long-term E. coli ABU isolates from
42 participants (median age 86, range 70–97) were identified and included in this
study. One subject carried two E. coli clones (LtABU20, LtABU24) with distinct
morphologies at three consecutive sampling points reaching maximum con-
centrations of >107 CFU/ml each. Most of the isolates originated from female
participants (41/42) with incontinence (39/41). A comprehensive analysis of bac-
teriology and risk factors associated with ABU at one of the two collections sites
was published previously53.
UZA_uro collection. The UZA_uro collection comprises urosepsis isolates
obtained from the Antwerp University Hospital UZA. Hospital records from 2015
to 2018 were screened for non-compromised patients with community-acquired
sepsis who had positive urine and blood cultures with matching E. coli isolates (i.e.,
identical antibiotic susceptibility patterns) separated in time by ≤1 week. Immu-
nocompromising conditions, surgery, pregnancy, urological intervention, and
putative hospital-acquired infection were exclusion criteria. Sepsis symptoms were
defined based on the SIRS criteria68. Infection was considered community-acquired
when the sampling date of either blood or urine culture was no more than 2 days
after admission to the hospital. Non-duplicate urosepsis isolates from 30 such
patients (median 75.5 years, range 0–92) were available.
MVAST_ABU collection. The MVAST_ABU collection comprises asymptomatic
bacteriuria isolates from male patients at the Minneapolis Veterans Affairs Medical
Center (MVAMC) without long-term care facility residence in the previous year.
The collection is a subset of isolates from various clinical sources described by
Drekonja et al.69.
MC_pye collection. The MC_pye collection comprises urine isolates from female
patients (>18 years of age) with acute, uncomplicated pyelonephritis originally
collected between 1994 and 1996 during a multi-center study in the United
States70,71. Inclusion criteria were flank pain/tenderness, fever (>38 °C), and pyuria.
Exclusion criteria included immunocompromised status, hospital admission, uro-
logic abnormalities, and diabetes. Of the 70 isolates of the MC_pye collection, 39
were sequenced here and 31 had publicly available genomic data.
Publicly available collections. Publicly available genomic data for 875 isolates
from 13 collections were considered for inclusion. Thirty-eight isolates were
excluded due to low sequence quality (n= 25), inaccessible or corrupted read files
(n= 8), inconclusive metadata (n= 4), or doubtful species (n= 1). Sixty-four
isolates from the KTE_and Rec_cys collections were excluded due to duplicate
sequencing of reported same-clone isolates from the same patients. The KTE
collection originally comprised 48 urinary isolates from 47 cystitis psatients, 81
fecal isolates from the same patients, which partially (n= 40) corresponded to the
infecting clone, and 67 fecal isolates from patients who never had a UTI (control).
The 40 fecal isolates that were reported to match to the cystitis clone in the same
patient18 were excluded. The Rec_cys collection originally comprised 43 E. coli
genomes obtained through consecutive sampling from 14 women with recurrent
cystitis43. Putative same-clone isolates were excluded. Thirty-five isolates from the
PUTI_cys, MC_pye, and MN_fec collections were excluded to correct for sampling
bias. PUTI_cys, MC_pye, and MN_fec comprised isolates originally selected for
sequencing based on presumptive ExPEC status (i.e., presence of at least two of the
genes papAH and/or papC, sfa/focDE, afa/draBC, iutA, and kpsMII), with an
ExPEC:non-ExPEC target ratio of approximately one72. For our analysis, strains
were randomly sub-selected to reflect the unbiased ExPEC/non-ExPEC ratio of the
source collection. Descriptions of all collections and details on exclusions are
provided in Table 1, Supplementary Table 1, and Supplementary Note 1.
Bacterial genomes of the CC131 dataset. Assemblies from CC131 isolates of the
main dataset were analyzed in the context of publicly available CC131 whole-
genome sequences including assemblies of 92 isolates from children with febrile
UTI73 defined here as invasive UPEC isolates, 10 urosepsis isolates17, 16 cystitis
isolates74, 52 isolates of various clinical phenotypes46, and 799 isolates without
available metadata randomly downloaded from Enterobase75. Forty-eight complete
or near-complete genomes of CC131 isolates identified on NCBI were also included
in the analysis. Details of all isolates included in the CC131 dataset are provided in
Supplementary Data 10 and collections are described in Supplementary Table 11.
Short-read sequencing. DNA was extracted from overnight liquid cultures (single
colonies inoculated in 4 mL Mueller Hinton broth) using the MasterPure Pur-
ification Kit (Epicentre). Libraries were prepared using Nextera XT (Illumina), and
sequencing performed on the Illumina MiSeq platform with 2 × 250 bp paired-end
chemistries.
Long-read sequencing. Twenty-four isolates (Supplementary Data 5) were addi-
tionally sequenced using single-molecule real-time (SMRT) technology (Pacific
Biosciences). DNA was extracted using the MagAttract HMW DNA Kit (Qiagen)
and sheared to ~8–10 kb using g-TUBE (Covaris). Libraries were prepared using
the PacBio SMRTbell template preparation kit version 1.0 and pooled libraries of
tagged isolates sequenced using the PacBio Sequel system.
De novo assemblies and annotation. Short-read data of 151 in-house sequenced
isolates were pooled with raw reads downloaded from publicly available sources
(NCBI’s Sequence Read Archive or National Genomics Data Center, 724 isolates).
Reads were trimmed using TrimGalore v0.4.4 (https://github.com/FelixKrueger/
TrimGalore) and assembled de novo with Spades v3.13.076. When long-read
sequencing data were available, assemblies were obtained using HGAP 477 with
default settings with subsequent short-read polishing with Pilon implemented in
Unicycler v0.4.878 and compared to hybrid assemblies performed with Unicycler
v0.4.8 using default settings. The best assembly based on the number of contigs and
N50 was used for further analyses. HGAP assemblies, which usually did not recover
plasmid sequences, were combined with plasmid assemblies obtained from hybrid
assemblies in Unicycler (see Supplementary Data 6). Contigs representing plasmids
were predicted using MLPlasmids79 and replicons identified using the Plas-
midFinder database80 in ABRicate v0.9.3 (https://github.com/tseemann/abricate)
(minimum sequence coverage/identity 70/90%). Pre-assembled data were down-
loaded from NCBI when raw read data were not accessible (17 reference strains
and 15 isolates of collection Rec_cys, see Supplementary Data 1). Assembly quality
was assessed using Quast81. Genomes of all 907 isolates were annotated using
Prokka v1.13.382.
Phylogenetic analysis. To generate core genome alignments, collinear blocks (i.e.,
homologous genomic regions free from internal rearrangements) in assemblies
were identified and aligned using Parsnp v1.283. Separate core genome alignments
were generated for the main dataset (907 isolates, reference genome UMN026,
GCA_000026325.2) and isolates belonging to CC69 (76 isolates, reference genome
UMN026, GCA_000026325.2), CC73 (164 isolates, reference genome CFT073,
GCA_000007445.1), CC95 (107 isolates, reference genome UTI89,
GCA_000013265.1), and CC131 (1076 isolates, reference genome JJ1886,
GCA_000493755.1). Prophage regions in reference genomes were identified by
PHASTER84 and masked from the respective alignments. Core genome alignments
were used to construct maximum-likelihood (ML) trees using RaXML v8.2.12 with
the generalized time-reversible (GTR) model and gamma distribution85. One
hundred bootstrap replicates were performed to assess support for the phylogeny.
ClonalFrameML v1.1286 was used to account for recombination events and to
correct branch lengths with the best RAxML tree as starting tree. To identify
lineages enriched with invasive UPEC isolates, the pre-computed phylogeny of all
907 isolates or of CC69, CC73, or CC95 isolates was partitioned into clusters on
multiple levels of resolution using Bayesian hierarchical clustering implemented in
the R package fastbaps87. Clusters identified in different phylogenies were merged
and the 129 clusters were tested for significant phenotype enrichment among
UPEC isolates using Fisher’s exact test. papGII+ lineages were defined based on
patristic distances (cutoff 0.00032) in the maximum-likelihood tree of papGII+
isolates using RAMI88. A lower cutoff distance (0.000052) was chosen for isolates
of CC73 to address the heterogenous population structure within this CC and
nested papGII+ clades combined. Phylogenetic trees and isolate metadata were
visualized in iTOL89 and annotated using Inkscape 0.92.
Fig. 5 Phylogenetic trees of isolates belonging to pandemic UPEC lineages CC69, CC95, and CC73. Midpoint rooted maximum-likelihood phylogenies
based on core genome alignments (CC69: 76 isolates, 25,753 variable sites in 4.006Mbp core genome; CC95: 107 isolates, 17,674 variable sites in 4.054
Mbp core genome; CC73: 164 isolates, 25,939 variable sites in 3.857Mbp core genome). Clinical phenotypes are labeled at the branch tips (ring 3). The
presence of papGII, papGIII, and iuc is shown (ring 2). When identification was possible, papGII+ PAI types are labeled (ring 1). Fragmented assemblies, lack
of resolved reference PAIs, and sequence deletions or insertions within PAIs sometimes prevented the determination of the specific papGII+ PAI type.
Isolates part of papGII+ lineages are shaded in red; isolates part of the same lineages but lacking papGII in bright red. Isolates with complete or near-
complete genomes used to investigate the genetic context of papGII are annotated. Red branch lines indicate nodes with bootstrap values <70. Branch
lengths of distantly related isolates (outgroup) are reduced and indicated as dashed lines. The papGII-negative subclade in CC95 corresponds to the
previously defined subgroup B (serotype O18:H7)45. The trees were visualized using iTOL89.
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Genome-wide association studies. Clusters of orthologous genes (COGs)
representing homologous genes with shared sequences were identified using Roary
v3.12.0 with a BLASTp identity cutoff of 95%90. The pan-genome of all isolates
comprised 37,717 COGs, of which 3067 COGs represented the core genome
(present in ≥99% of all isolates). Pan-genome-wide association studies (pan-
GWAS) on the COG presence-absence matrix were performed on 30705 COGs (of
which 2237 were present in all isolates) identified in 722 UPEC isolates using the R
package treeWAS v1.0 with Bonferroni correction91. Fecal isolates were excluded
from pan-GWAS and DBGWAS analyses due to their unknown urinary pheno-
type. Associations of each COG with invasive or non-invasive UPEC isolates were
calculated using the Fisher’s exact tests. The significance threshold (raw P= 1.42 ×
10−18, corresponding to a Bonferroni-corrected P= 4.04 × 10−14) was determined
from a simulated dataset accounting for population structure as described in
treeWAS. Manhattan plots were generated using the R package CMplot (https://
github.com/YinLiLin/R-CMplot). PAIs in the genome of reference strain UMN026
were identified using Islander implemented in IslandViewer 492. Genetic associa-
tions were additionally analyzed with DBGWAS v0.5.426 with a q-value threshold
of 0.05.
Genotyping. Phylogroups were determined according to phylogenetic clustering
and supported by in silico typing using ClermonTyping v1.493. Multi-locus
sequence types (ST) of the Achtmann scheme were determined using srst2 v0.2.094
with default settings or mlst v2.16.1 (https://github.com/tseemann/mlst). Identified
STs were grouped into clonal complexes (CC) according to the scheme available at
EnteroBase75. Alleles of type 1 fimbrial tip adhesin gene fimH were identified using
FimTyper v1.195. H and O serotypes were predicted in silico with the EcOH
database96 using srst2 v0.2.094 with default settings, or, in case no raw read data
were available, ABRicate v0.9.3 (minimum sequence coverage/identity 70/90%).
Pointfinder97 was used to search for mutations in the quinolone resistance-
determining regions (QRDR). Resistance genes were identified using ABRicate
v0.9.3 in conjunction with the resfinder database98 (minimum sequence coverage/
identity 70/90%). Prophage genes and regions were identified using PHASTER84
with annotated genbank files as input. Clades of CC131 were confirmed using
ABRicate v0.9.3 by screening assemblies against the clade B-specific allele of prfC
identified in isolate KTE6 (minimum sequence coverage/identity 100/99%), the
clade C2-specific allele of ybbW identified in isolate JJ1886 (minimum sequence
coverage/identity 100/99%), and the clade C1-specific allele of a gene with locus tag
U12A_RS05235 identified in isolate U12A (exact matches).
Screening for virulence-associated genes. An E. coli virulence-associated gene
database (EcVGDB99) was compiled from two separate collections of E. coli
virulence factors, ecoli_VF_collection100 and ecoli_vf (https://github.com/phac-
nml/ecoli_vf), which are both based on the virulence factor database VFDB101.
Redundant sequences identified using cdhit102 were removed. The database was
supplemented with additional virulence-associated genes (VAGs) from the litera-
ture, resulting in 1368 sequences representing 1072 VAGs of 14 virulence factor
categories. Genome assemblies were screened against the EcVGDB using ABRicate
(minimum sequence coverage/identity 70/90%). The presence of alleles of the
virulence gene families papG and afa/dra was additionally assessed by read map-
ping using srst294 using default settings, accepting hits with no or minor mis-
matches (SNPs or indels). iuc locus variants were determined by mapping reads to
the reference genes shiF, shiFp, iutA1, and iutA2 obtained from the genomes of
isolates CFT073, US06, and IAI39 (srst294, default settings). Hits with indels or
holes were rejected. When read data was not available, iuc variants were deter-
mined using ABRicate with the three complete operons as reference (minimum
sequence coverage/identity 70/90%).
Identification and clustering of mobile genetic elements. Completely resolved
papGII-containing PAIs, and PAIs or plasmids containing the iuc locus, were
extracted from high-quality genome assemblies. To estimate their similarity, mash
distance matrices were produced using mashtree v1.12103, and the genetic elements
hierarchically clustered in R v3.5.3. papGII-containing PAIs were clustered by
applying a mash distance cutoff of 0.04. Mash distances are an estimate of sequence
similarity calculated from the fraction of shared k-mers (Jaccard index) in Min-
Hash sketches104. PyANI v0.2.9105 with BLAST+106 was used to identify the
pairwise alignment coverage of PAIs. For the comparison of resolved PAIs of the
same type across clonal complexes, the lower of the two alignment coverage values
resulting from subject and query choice of each pair was chosen. To predict
papGII+ PAI types in papGII+ isolates with insufficient sequence assemblies, their
sequencing reads were mapped to the 42 resolved papGII+ PAIs using srst294 with
default settings. Identified hits with ≥90% identity and ≥90% coverage were
screened for homologs with no or minor mismatches (SNPs or indels) and assigned
to the corresponding papGII+ PAI type. Hits with large deletions or truncations
(“holes”) were counted as mismatches. Hits in isolates with both papGII+ and
papGIII-containing PAIs, particularly observed in papGII+ lineages of CC73, could
lead to ambiguous hits which were excluded due to possible recombination events
between the two pap-containing PAIs.
Detection of integration sites of papGII-containing PAIs. ABRicate v0.9.3
(minimum sequence coverage/identity 70/90%) was used to query the genomic
position of papGII and housekeeping genes surrounding the six identified inte-
gration sites (tRNA-pheV: speC – kpsFII or gspM/yghD; tRNA-pheU: yjdC – cadC;
tRNA-selC: yicL – yicJ; tRNA-leuX: yjgB – gntP/uxuA; ula: ulaE – ulaD; gln: glnP –
glnH) in each genome assembly. Integration sites were then inferred from the
chromosomal distance between papGII and the surrounding housekeeping genes.
The integration site could not be inferred from assemblies with highly fragmented
PAIs, which was often the case in isolates with multiple pap operons.
Multiple sequence alignments and visualization of genomes and PAIs. Gene
and protein sequences were aligned using Muscle v3.8.31107 and their phylogenetic
relationship reconstructed using a GTR model in Mega-X v10.0.5108. Percent
sequence identity matrices were calculated using Clustal2.1109. Schematic repre-
sentations and comparisons of genomes and PAIs were generated using EasyFig
2.2.3110.
Statistical tests. Statistical analyses were performed using R v3.5.3. Frequency
counts were compared using two-tailed Fisher’s exact test, while continuous
variables were analyzed using two-tailed Mann–Whitney U test. Bonferroni
adjusted P values of <0.05 were considered to reflect statistical significance, except
in the GWAS analyses.
Material availability. Requests for obtaining clinical isolates collected as part of
this study should be addressed to the corresponding author. Exchange of clinical
isolates should always be in agreement with the University of Antwerp.
Ethics. Ethical approval for the study was received from the ethics committee UZA
(approval No. 17/08/081, No. 20/11/119, and No. 18/10/122). Written informed
consent was obtained from all subjects participating in the clinical investigation or,
when the participant was not capable of giving consent, by his or her legal
representative.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Illumina and PacBio reads generated for this study are available at the NCBI Sequence
Read Archive (SRA) under BioProject no. PRJNA592372. Complete or draft genome
assemblies have been submitted to NCBI GenBank. Individual accession numbers are
provided in Supplementary Data 1. Sequences of papGII+ PAIs and the curated E. coli
virulence gene database (EcVGDB) are provided at https://github.com/MBiggel/
UPEC_study (https://doi.org/10.5281/zenodo.4079473). An interactive version of the
core genome phylogeny of the 907 E. coli isolates is accessible at https://microreact.org/
project/O4QAYAJWw. All other relevant data are available from the corresponding
authors. Public data utilized in this study include genomic data (accession numbers
provided in Supplementary Data 1 and 10), the databases plasmidfinder, resfinder,
EcOH, ecoli_vf, ecoli_VF_collection, and the EnteroBase ST/CC scheme.
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